Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Bing Zhao, MD
CONTACT
Sophia Paspal, PhD RAC
CONTACT
Lead
Xynomic Pharmaceuticals, Inc.
An open-label, single-arm, multi-center phase 2 study to evaluate the efficacy and safety of oral histone deacetylase (HDAC)-inhibitor abexinostat, as monotherapy in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
